Back to top

messenger-rna: Archive

Zacks Equity Research

MRNA Stock Jumps on CDC's Revised RSV Vaccine Recommendations

Moderna rises as CDC expands RSV vaccine guidance to include high-risk adults aged 50-59, boosting mResvia's reach.

GSKNegative Net Change PFEPositive Net Change MRNAPositive Net Change

Sundeep Ganoria

Will AbbVie's Acquisition Spree Aid Pipeline Growth?

ABBV's $2.1 billion Capstan deal and 20+ recent acquisitions sharpen its pipeline edge across immunology and beyond.

SNYNegative Net Change LLYPositive Net Change ABBVNegative Net Change

Zacks Equity Research

Moderna Stock Gains on Encouraging Flu Vaccine Data

MRNA's mRNA-1010 flu vaccine outperforms GSK's shot by 26.6% in a large phase III trial of adults 50 and older.

GSKNegative Net Change MRNAPositive Net Change AGENPositive Net Change AMRNPositive Net Change